Substantial clinical and economic burden was observed in patients with OI in US clinical practice. These findings may inform evaluation of disease-modifying therapies.
No takes yet. Share an insight, caveat, or question.
Abraham et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: